Essential Biotechnology's Biz Plan Competition Round

Essential Biotechnology raised a round of funding on December 24, 2015. Investors include Bridge to Cures.

Essential Biotechnology has a new approach to cancer therapy. Existing targeted therapies typically slow the growth of tumors by inhibition of a particular signaling pathway in tumor cells. With chemo…

Articles about Essential Biotechnology's Biz Plan Competition Round: